11
Views
1
CrossRef citations to date
0
Altmetric
Chemical Pathology

Serum prohepcidin concentrations in rheumatoid arthritis

, &
Pages 178-182 | Received 03 Jan 2008, Accepted 14 Feb 2008, Published online: 06 Jul 2009

References

  • Andrews N C. Molecular control of iron metabolism. Best Pract Res Clin Haematol 2005; 18: 159–169
  • Philpott C C. Molecular aspects of iron absorption: insights into the role of HFE in haemochromatosis. Hepatology 2002; 35: 993–1001
  • Fleming R E. Advances in understanding the molecular basis for the regulation of dietary iron absorption. Curr Opin Gastroentrol 2005; 21: 201–206
  • Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003; 102: 783–788
  • Feder J N, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399–408
  • Papanicolaou G, Samuels M E, Ludwig E H, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 2004; 36: 77–82
  • Park C H, Valore E V, Waring A J, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesised in the liver. J Biol Chem 2001; 276: 7806–7810
  • Krause A, Neitz S, Magert H J, et al. LEAP–1, a novel highly disulphide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 2000; 480: 147–150
  • Pigeon C, Ilyin G, Courselaud B, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001; 276: 7811–7819
  • Nicolas G, Bennoun M, Porteu A, et al. Severe iron deficiency anaemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 2002; 99: 4596–4601
  • Nicolas G, Chauvet C, Viatte L, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002; 110: 1037–1044
  • Ganz T. Hepcidin – a regulator of intestinal iron absorption and iron recycling by macrophages. Best Pract Res Clin Haematol 2005; 18: 171–182
  • Bridle K R, Frazer D M, Wilkins S J, et al. Disrupted hepcidin regulation in HFE-associated haemachromatosis and the liver as a regulator of body iron homeostasis. Lancet 2003; 361: 669–673
  • Gehrke S G, Kulaksiz H, Herrmann T, et al. Expression of hepcidin in hereditary haemachromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron. Blood 2003; 102: 371–376
  • Nemeth E, Valore E V, Territo M, et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute phase protein. Blood 2003; 101: 2461–2463
  • Murphy A T, Witcher D R, Luan P, Wroblewski V J. Quantitation of hepcidin from human and mouse serum using liquid chromatography tandem mass spectrometry. Blood 2007; 110: 1048–1054
  • Kemna E, Tjalsma H, Laarakkers C, et al. Novel urine hepcidin assay by mass spectrometry. Blood 2005; 106: 3268–3270
  • Kulaksiz H, Gehrke S G, Janetzko A, et al. Prohepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemachromatosis, chronic renal failure, and renal anaemia. Gut 2004; 53: 735–743
  • Hadley K B, Johnson L K, Hunt J R. Iron absorption by healthy women is not associated with either serum or urine prohepcidin. Am J Clin Nutr 2006; 84: 150–155
  • Roe M A, Spinks C, Heath A L, et al. Serum prohepcidin concentration: no association with iron absorption in healthy men; and no relationship with iron status in men carrying HFE mutations, hereditary haemochromatosis patients undergoing phlebotomy treatment, or pregnant women. Br J Nutr 2007; 97: 544–549
  • Theurl I, Mattle V, Seifert M, Mariani M, Marth C, Weiss G. Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease. Blood 2006; 107: 4142–4148
  • Arnett F C, Edworthy S M, Bloch D A, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–324
  • Kasvosve I, Delanghe J. Total iron binding capacity and transferrin concentration on the assessment of iron status. Clin Chem Lab Med 2002; 40: 1014–1018
  • Brittenham G M, Weiss G, Brissot P, et al. Clinical consequences of new insights in the pathophysiology of disorders of iron and heme metabolism. Am Soc Hematol Educ Program 2000; 39–50
  • Cartwright G E. The anaemia of chronic disorders. Semin Hematol 1966; 3: 351–375
  • Baer A N, Disyporis E N, Krantz S B. The pathogenesis of anaemia in rheumatoid arthritis. A clinical and laboratory analysis. Semin Arthritis Rheum 1990; 19: 209–223
  • Weiss G, Goodnough L T. Medical progress: anemia of chronic disease. N Engl J Med 2005; 352: 1011–1023
  • Kurer S B, Seifert B, Michel B, et al. Prediction of iron deficiency in chronic inflammatory rheumatic disease anaemia. Br J Haematol 1995; 91: 820–826
  • Chijiwa T, Nishiya K, Hashomoto K. Serum transferrin receptor levels in patients with rheumatoid arthritis are correlated with indicators for anaemia. Clin Rheumatol 2001; 20: 307–313
  • Malyszko J, Malyszko J S, Hryszko T, et al. Is hepcidin a link between anemia, inflammation and liver function in hemodialyzed patients?. Am J Nephrol 2005; 25: 586–590
  • Kohgo Y, Niitsu Y, Kondo H, et al. Serum transferrin receptor as a new index of erythropoiesis. Blood 1987; 70: 1955–1958
  • Dallalio G, Fleury T, Means R T, Jr. Serum hepcidin in clinical specimens. Br J Haematol 2003; 122: 996–1000

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.